Macleods Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.12 M
as on 04-07-2024
- Company Age 37 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 12.50 Cr
as on 04-07-2024
- Revenue 9.61%
(FY 2022)
- Profit 10.90%
(FY 2022)
- Ebitda 10.89%
(FY 2022)
- Net Worth 5.92%
(FY 2022)
- Total Assets 5.87%
(FY 2022)
About Macleods Laboratories
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M.
The company has closed loans amounting to ₹12.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajendra Agarwal and Banwarilal Bawri serve as directors at the Company.
- CIN/LLPIN
U85195MH1987PTC045607
- Company No.
045607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Macleods Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Agarwal  | Director | 16-Dec-1987 | Current |
| Banwarilal Bawri | Director | 16-Dec-1987 | Current |
Financial Performance and Corporate Structure Insights of Macleods Laboratories.
Macleods Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.61% increase. The company also saw a substantial improvement in profitability, with a 10.9% increase in profit. The company's net worth moved up by a moderate rise of 5.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macleods Laboratories?
In 2018, Macleods Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Macleods Pharmaceuticals LtdActive 35 years 6 monthsRajendra Agarwal and Banwarilal Bawri are mutual person
- Ratnidevi Murlidhar Bawri Social Welfare FoundationActive 9 years 6 months
Rajendra Agarwal is a mutual person
East And West Clothing Private LimitedActive 49 years 11 monthsRajendra Agarwal and Banwarilal Bawri are mutual person
- Agarwal Holdings Private LimitedActive 4 years 8 days
Rajendra Agarwal and Banwarilal Bawri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Dec 2000 | ₹12.50 Cr | Satisfied |
How Many Employees Work at Macleods Laboratories?
Unlock and access historical data on people associated with Macleods Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macleods Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macleods Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
